1. Fellmann, Florence, Saunders, Carol, O'Donohue, Marie-Françoise, Davis, Erica E, Gleizes, Pierre-Emmanuel. 2024. An atypical form of 60S ribosomal subunit in Diamond-Blackfan anemia linked to RPL17 variants. In JCI insight, 9, . doi:10.1172/jci.insight.172475. https://pubmed.ncbi.nlm.nih.gov/39088281/
2. Zhuang, Xianbo, Zhang, Guifeng, Bao, Mengxin, Wang, Zheng, Sun, Xiujuan. 2023. Development of a novel immune infiltration-related diagnostic model for Alzheimer's disease using bioinformatic strategies. In Frontiers in immunology, 14, 1147501. doi:10.3389/fimmu.2023.1147501. https://pubmed.ncbi.nlm.nih.gov/37545529/
3. Ko, Min Ji, Seo, Yu-Ri, Seo, Daekwan, Kim, Kwang Seok, Lee, Yun-Han. 2022. RPL17 Promotes Colorectal Cancer Proliferation and Stemness through ERK and NEK2/β-catenin Signaling Pathways. In Journal of Cancer, 13, 2570-2583. doi:10.7150/jca.69428. https://pubmed.ncbi.nlm.nih.gov/35711835/
4. Lari, Arezou, Pourbadie, Hamid Gholami, Sharifi-Zarchi, Ali, Jamshidi, Ahmadreza, Mahmoudi, Mahdi. 2021. Dysregulation of ribosome-related genes in ankylosing spondylitis: a systems biology approach and experimental method. In BMC musculoskeletal disorders, 22, 789. doi:10.1186/s12891-021-04662-2. https://pubmed.ncbi.nlm.nih.gov/34521416/
5. Smolock, Elaine M, Korshunov, Vyacheslav A, Glazko, Galina, Gerloff, Janice, Berk, Bradford C. 2012. Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation. In Circulation, 126, 2418-27. doi:10.1161/CIRCULATIONAHA.112.125971. https://pubmed.ncbi.nlm.nih.gov/23065385/